Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways

Lili Zhao1, Tina Samuels, Sarah Winckler

  • 1Department of Pharmacology, College of Medicine, The University of Iowa, Iowa City, IA 52242, USA.

Insights

Cyclin G1, a p53-responsive gene, regulates cell growth by interacting with the ARF-Mdm2-p53 pathway. It induces cell cycle arrest, particularly when p53 is activated, and is modulated by Mdm2.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Cyclin G1 is a p53-responsive gene induced in alternative reading frame (ARF)-arrested cells.
  • Its precise role in cellular growth control and tumor suppression remains largely undefined.

Purpose of the Study:

  • To investigate the effects of Cyclin G1 on mammalian cell growth.
  • To elucidate Cyclin G1's involvement in the ARF-Mdm2-p53 tumor suppressor pathway.

Main Methods:

  • In vitro and in vivo interaction studies involving Cyclin G1, ARF, Mdm2, and p53.
  • Cell cycle analysis to determine growth arrest phases.
  • Investigation of Cyclin G1 regulation by Mdm2 and its dependence on p53 and retinoblastoma protein (pRb).

Main Results:

  • Cyclin G1 interacts with ARF, Mdm2, and p53.
  • High Cyclin G1 levels induce G1-phase arrest and p53 activation; lower levels potentiate ARF-mediated arrest.
  • Mdm2 down-regulates Cyclin G1 via proteasomal degradation, suggesting Mdm2 restrains Cyclin G1's feedback regulation of p53.
  • Cyclin G1-induced growth inhibition is partially dependent on pRb, not solely on p53.

Conclusions:

  • Cyclin G1 acts as a positive feedback regulator of p53, with its expression controlled by Mdm2.
  • Cyclin G1 possesses intrinsic growth inhibitory activity linked to both the ARF-p53 and pRb tumor suppressor pathways.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.